Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Sasadeusz

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2020
Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?Jennifer Audsley, Anchalee Avihingsanon, Margaret Littlejohn, et al.
Antiviral Therapy|January 17, 2014
CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapyPaola Giarda, Anchalee Avihingsanon, Joe Sasadeusz, et al.
Communicable Diseases Intelligence (2018)|July 18, 2024
To B or not to B: how the hepatitis B surveillance case definition can misdirect public health actionsAnna B Pierce, Simon Crouch, Edura Jalil, et al.
Internal Medicine Journal|December 2, 2024
Emerging concepts of CMV in transplantationGlen P Westall, David Gottlieb, Peter Hughes, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 22, 2022
Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infectionGenevieve Douglas, Michelle K Yong, Shio Yen Tio, et al.
Biomedicines|October 29, 2025
Pharmacokinetics of Sofosbuvir and Velpatasvir for Hepatitis C Treatment in PregnancyMichelle L Giles, Alexandra Dunbar, Sushena Krishnaswamy, et al.
Journal of Medical Virology|November 2, 2017
HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcomeShu Su, Christopher K Fairley, Joe Sasadeusz, et al.
Emerging Infectious Diseases|July 14, 2011
Pandemic (H1N1) 2009 risk for frontline health care workersCaroline Marshall, Anne Kelso, Emma McBryde, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2007
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfectionMilos Opravil, Joe Sasadeusz, David A Cooper, et al.
Human Immunology|September 17, 2011
No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virusDamon P Eisen, Caroline Marshall, Melinda M Dean, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2020
Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?Jennifer Audsley, Anchalee Avihingsanon, Margaret Littlejohn, et al.
Antiviral Therapy|January 17, 2014
CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapyPaola Giarda, Anchalee Avihingsanon, Joe Sasadeusz, et al.
Communicable Diseases Intelligence (2018)|July 18, 2024
To B or not to B: how the hepatitis B surveillance case definition can misdirect public health actionsAnna B Pierce, Simon Crouch, Edura Jalil, et al.
Internal Medicine Journal|December 2, 2024
Emerging concepts of CMV in transplantationGlen P Westall, David Gottlieb, Peter Hughes, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 22, 2022
Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infectionGenevieve Douglas, Michelle K Yong, Shio Yen Tio, et al.
Biomedicines|October 29, 2025
Pharmacokinetics of Sofosbuvir and Velpatasvir for Hepatitis C Treatment in PregnancyMichelle L Giles, Alexandra Dunbar, Sushena Krishnaswamy, et al.
Journal of Medical Virology|November 2, 2017
HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcomeShu Su, Christopher K Fairley, Joe Sasadeusz, et al.
Emerging Infectious Diseases|July 14, 2011
Pandemic (H1N1) 2009 risk for frontline health care workersCaroline Marshall, Anne Kelso, Emma McBryde, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2007
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfectionMilos Opravil, Joe Sasadeusz, David A Cooper, et al.
Human Immunology|September 17, 2011
No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virusDamon P Eisen, Caroline Marshall, Melinda M Dean, et al.
Pageof 7